Facilitatory effect of aspirin on glutamate release from rat hippocampal nerve terminals: Involvement of protein kinase C pathway

Neurochemistry International

Volumn 48, Issue 3, 2006, Pages 181-190

  Wang, Su Jane ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Aspirin; Ca2+ influx; Glutamate exocytosis; Hippocampal synaptosomes; Protein kinase C

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATASE; AMINO ACID RECEPTOR BLOCKING AGENT; ARACHIDONIC ACID; BAFILOMYCIN A1; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; GLUTAMIC ACID; ICOSATETRAENOIC ACID; IONOMYCIN; L TRANSPYRROLIDINE 2,4 DICARBOXYLIC ACID; PROTEIN KINASE C; UNCLASSIFIED DRUG;

AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HIPPOCAMPUS; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE;

ANIMALS; ASPIRIN; CALCIUM CHANNEL BLOCKERS; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE ENDINGS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE;

ANIMALIA;

EID: 30544448473     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.10.006     Document Type: Article

References (48)

1. P.S. Aisen Anti-inflammatory agents in Alzheimer's disease Curr. Neurol. Neurosci. Rep. 2 2002 405 409
2. 2(5) J. Neurochem. 48 1987 552 559
3. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O'Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421
4. K. Andersen, L.J. Launer, A. Ott, A.W. Hoes, M.M. Breteler, and A. Hofman Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study Neurology 45 1995 1441 1445
5. A.P. Barrie, D.G. Nicholls, J. Sanchez-Prieto, and T.S. Sihra An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes J. Neurochem. 57 1991 1398 1404
6. D.K. Bartschat, and T.E. Rhodes Protein kinase C modulates calcium channels in isolated presynaptic nerve terminals of rat hippocampus J. Neurochem. 64 1995 2064 2072
7. J.M. Bekkers, and C.F. Stevens Presynaptic mechanism for long-term potentiation in the hippocampus Nature 346 1990 724 729
8. T.V. Bliss, and G.L. Collingridge A synaptic model of memory: long-term potentiation in the hippocampus Nature 361 1993 31 39
9. 2 blocking drugs Neurobiol. Aging 16 1995 523 530
10. P. Crisanti, A. Leon, D.M. Lim, and B. Omri Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition J. Neurochem. 93 2005 1587 1593
11. J.L. Cummings, H.V. Vinters, G.M. Cole, and Z.S. Khachaturian Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities Neurology 51 1998 S2 S17
12. 2+ in hippocampal mossy fiber nerve endings Neurochem. Res. 18 1993 1231 1237
13. C.J. De, A. Cardenas, I. Lizasoain, J.C. Leza, P. Fernandez-Tome, P. Lorenzo, and M.A. Moro Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation Stroke 33 2002 261 267
14. N.B. Farber, J.W. Newcomer, and J.W. Olney The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease Prog. Brain Res. 116 1998 421 437
15. E.J. Freeman, D.M. Terrian, and R.V. Dorman Presynaptic facilitation of glutamate release from isolated hippocampal mossy fiber nerve endings by arachidonic acid Neurochem. Res. 15 1990 743 750
16. M. Grilli, M. Pizzi, M. Memo, and P. Spano Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation Science 274 1996 1383 1385
17. 2+ indicators with greatly improved fluorescence properties J. Biol. Chem. 260 1985 3440 3450
18. K.J. Hee, and F. Grodstein Regular use of nonsteroidal anti-inflammatory drugs and cognitive function in aging women Neurology 60 2003 1591 1597
19. I. Herrero, M.T. Miras-Portugal, and J. Sanchez-Prieto Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation Nature 360 1992 163 166
20. J.J. Hoozemans, A.J. Rozemuller, I. Janssen, C.J. De Groot, R. Veerhuis, and P. Eikelenboom Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain Acta Neuropathol. (Berl) 101 2001 2 8
21. 2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex Trends Pharmacol. Sci. 22 2001 519 525
22. N. Khayyam, P. Thavendiranathan, F.J. Carmichael, B. Kus, V. Jay, and W.M. Burnham Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia Neuroreport 10 1999 371 374
23. D.J. Linden, and A. Routtenberg The role of protein kinase C in long-term potentiation: a testable model Brain Res. Brain Res. Rev. 14 1989 279 296
24. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N. Engl. J. Med. 330 1994 613 622
25. M.A. Lynch, and K.L. Voss Arachidonic acid increases inositol phospholipid metabolism and glutamate release in synaptosomes prepared from hippocampal tissue J. Neurochem. 55 1990 215 221
26. P.L. McGeer, M. Schulzer, and E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies Neurology 47 1996 425 432
27. P.L. McGeer, and E.G. McGeer The inflammatory response system of brain implications for therapy of Alzheimer and other neurodegenerative diseases Brain Res. Brain Res. Rev. 21 1995 195 218
28. H.T. McMahon, and D.G. Nicholls The bioenergetics of neurotransmitter release Biochim. Biophys. Acta 1059 1991 243 264
29. B. Meldrum, and J. Garthwaite Excitatory amino acid neurotoxicity and neurodegenerative disease Trends Pharmacol. Sci. 11 1990 379 387
30. E.D. Menschik, and L.H. Finkel Neuromodulatory control of hippocampal function: towards a model of Alzheimer's disease Artif. Intell. Med. 13 1998 99 121
31. D.G. Nicholls, and T.S. Sihra Synaptosomes possess an exocytotic pool of glutamate Nature 321 1986 772 773
32. D.G. Nicholls, T.S. Sihra, and J. Sanchez-Prieto Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry J. Neurochem. 49 1987 50 57
33. S.E. Nilsson, B. Johansson, S. Takkinen, S. Berg, S. Zarit, G. McClearn, and A. Melander Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years Eur. J. Clin. Pharmacol. 59 2003 313 319
34. G.M. Pasinetti, and P.S. Aisen Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain Neuroscience 87 1998 319 324
35. C.A. Reid, D.B. Dixon, M. Takahashi, T.V. Bliss, and A. Fine Optical quantal analysis indicates that long-term potentiation at single hippocampal mossy fiber synapses is expressed through increased release probability, recruitment of new release sites, and activation of silent synapses J. Neurosci. 24 2004 3618 3626
36. J.B. Rich, D.X. Rasmusson, M.F. Folstein, K.A. Carson, C. Kawas, and J. Brandt Nonsteroidal anti-inflammatory drugs in Alzheimer's disease Neurology 45 1995 51 55
37. T.J. Rink, C. Montecucco, T.R. Hesketh, and R.Y. Tsien Lymphocyte membrane potential assessed with fluorescent probes Biochim. Biophys. Acta 595 1980 15 30
38. N. Saito, A. Itouji, Y. Totani, I. Osawa, H. Koide, N. Fujisawa, K. Ogita, and C. Tanaka Cellular and intracellular localization of epsilon-subspecies of protein kinase C in the rat brain; presynaptic localization of the epsilon-subspecies Brain Res. 607 1993 241 248
39. T.S. Sihra Protein phosphorylation and dephosphorylation in isolated nerve terminals (synaptosomes) H.C. Hemmings Jr. Regulatory Protein Modification: Techniques and Protocols 1997 Humana Press Totowa, New Jersey 67 119
40. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release J. Biol. Chem. 267 1992 1983 1989
41. C.F. Stevens, and J.M. Sullivan Regulation of the readily releasable vesicle pool by protein kinase C Neuron 21 1998 885 893
42. W.F. Stewart, C. Kawas, M. Corrada, and E.J. Metter Risk of Alzheimer's disease and duration of NSAID use Neurology 48 1997 626 632
43. 2+ and glutamate release J. Neurochem. 53 1989 1693 1699
44. T.J. Turner, and K. Dunlap Pharmacological characterization of presynaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion Neuropharmacology 34 1995 1469 1478
45. J.R. Vane, Y.S. Bakhle, and R.M. Botting Cyclooxygenases 1 and 2 Annu. Rev. Pharmacol. Toxicol. 38 1998 97 120
46. N. Vartiainen, V. Keksa-Goldsteine, G. Goldsteins, and J. Koistinaho Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture J. Neurochem. 82 2002 329 335
47. E. Vazquez, and J. Sanchez-Prieto Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals Eur. J. Neurosci. 9 1997 2009 2018
48. 2+ channels in supporting hippocampal synaptic transmission Science 264 1994 107 111